Page last updated: 2024-09-05

hmr 1766 and warfarin

hmr 1766 has been researched along with warfarin in 1 studies

Compound Research Comparison

Studies (hmr 1766)	Trials (hmr 1766)	Recent Studies (post-2010) (hmr 1766)	Studies (warfarin)	Trials (warfarin)	Recent Studies (post-2010) (warfarin)
23	1	11	36,573	2,143	14,728

Protein Interaction Comparison

Protein	Taxonomy	hmr 1766 (IC50)	warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1	Homo sapiens (human)		0.0088

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, R; Haefeli, WE; Hirschfeld-Warneken, A; Lehr, KH; Mikus, G; Oberwittler, H; Teichert, L; Wesch, R; Willerich, H	1

Trials

1 trial(s) available for hmr 1766 and warfarin

Article	Year
Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766. Journal of clinical pharmacology, 2007, Volume: 47, Issue:1 Topics: Administration, Oral; Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2C9; Double-Blind Method; Guanylate Cyclase; Humans; Male; Nephelometry and Turbidimetry; ortho-Aminobenzoates; Prothrombin Time; Sulfonamides; Tablets; Time Factors; Warfarin	2007

Article

Year

Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.

Journal of clinical pharmacology, 2007, Volume: 47, Issue:1

Topics: Administration, Oral; Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2C9; Double-Blind Method; Guanylate Cyclase; Humans; Male; Nephelometry and Turbidimetry; ortho-Aminobenzoates; Prothrombin Time; Sulfonamides; Tablets; Time Factors; Warfarin

2007